Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes

Herein, we describe recruitment efforts for a trial of lipid-lowering medications in adolescents with type 1 diabetes, age 12–21 years. Based on our experience, future studies will require multiple centers to enroll a sufficient number of participants for adequate data to direct dyslipidemia medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bishop, Franziska K, Wadwa, R Paul, Ellis, Sam, Rewers, Marian, Maahs, David M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476991/
https://www.ncbi.nlm.nih.gov/pubmed/22846167
http://dx.doi.org/10.1186/1687-9856-2012-24
_version_ 1782247151634481152
author Bishop, Franziska K
Wadwa, R Paul
Ellis, Sam
Rewers, Marian
Maahs, David M
author_facet Bishop, Franziska K
Wadwa, R Paul
Ellis, Sam
Rewers, Marian
Maahs, David M
author_sort Bishop, Franziska K
collection PubMed
description Herein, we describe recruitment efforts for a trial of lipid-lowering medications in adolescents with type 1 diabetes, age 12–21 years. Based on our experience, future studies will require multiple centers to enroll a sufficient number of participants for adequate data to direct dyslipidemia medication treatment guidelines for adolescents with type 1 diabetes.
format Online
Article
Text
id pubmed-3476991
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34769912012-10-20 Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes Bishop, Franziska K Wadwa, R Paul Ellis, Sam Rewers, Marian Maahs, David M Int J Pediatr Endocrinol Letter to the Editor Herein, we describe recruitment efforts for a trial of lipid-lowering medications in adolescents with type 1 diabetes, age 12–21 years. Based on our experience, future studies will require multiple centers to enroll a sufficient number of participants for adequate data to direct dyslipidemia medication treatment guidelines for adolescents with type 1 diabetes. BioMed Central 2012 2012-07-30 /pmc/articles/PMC3476991/ /pubmed/22846167 http://dx.doi.org/10.1186/1687-9856-2012-24 Text en Copyright ©2012 Bishop et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Bishop, Franziska K
Wadwa, R Paul
Ellis, Sam
Rewers, Marian
Maahs, David M
Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes
title Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes
title_full Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes
title_fullStr Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes
title_full_unstemmed Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes
title_short Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes
title_sort lessons learned from a lipid lowering trial in adolescents with type 1 diabetes
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476991/
https://www.ncbi.nlm.nih.gov/pubmed/22846167
http://dx.doi.org/10.1186/1687-9856-2012-24
work_keys_str_mv AT bishopfranziskak lessonslearnedfromalipidloweringtrialinadolescentswithtype1diabetes
AT wadwarpaul lessonslearnedfromalipidloweringtrialinadolescentswithtype1diabetes
AT ellissam lessonslearnedfromalipidloweringtrialinadolescentswithtype1diabetes
AT rewersmarian lessonslearnedfromalipidloweringtrialinadolescentswithtype1diabetes
AT maahsdavidm lessonslearnedfromalipidloweringtrialinadolescentswithtype1diabetes

Ejemplares similares